Daigneault Alessandra (CIK 0001864648)

Latest company ownership

Role: General Counsel & Secretary
Shares held
7,502
Last filed at
Nov 2, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 19, 2021 Nov 2, 2021 NRX Pharmaceuticals, Inc. General Counsel & Secretary Sell 20.0 -33,715 -100.00% $442K